Antioxidants help arteries stay healthyLong-term supplementation with dietary antioxidants has a positive effect on glucose and fat metabolism, blood pressure and arterial flexibility in patients with multiple cardiovascular risk factors. The researchers, writing in BioMed Central open access journal Nutrition and Metabolism report these positive results in a randomized controlled trial of combined vitamin C, vitamin E, coenzyme Q10 and selenium capsules.
Notes: Effect of long-term treatment with antioxidants on arterial compliance, humoral factors and inflammatory markers in patients with multiple cardiovascular risk factors. Marina Shargorodsky, Ortal Debbi.
Previous results from clinical trials in the cardiovascular health effects of antioxidants are unique. More the matter the matter, Zimlichman and colleagues randomly assigned 70 patients obtained either antioxidants or placebo capsules for six months to receive. Tests at the beginning of the months that after three months and the six months mark, that the patients in the group of antioxidants more elastic arteries and better blood sugar and cholesterol had profiles.Over NovartisNovartis Pharmaceuticals Corporation designed, manufactures, markets and markets leading innovative prescription drugs of to treat a variety of diseases and conditions, including dermatological the cardiovascular, metabolic, organ transplantations and central nervous system, treating, gastrointestinal and respiratory territories. The company’s mission is to further improve the lives of people through pioneering new solutions to the healthcare.
This destruction hampered the capacity of nerve to to send electrical signal on what. To problems with the muscular movement of, coordination, balance and cognition.. New phase II dates day showed that up to 77 percent of patients who again day oral Sex FTY720 has were left free of recurrences over two years. You well as cared have a low inflammatory disease of considering by magnetic resonance imaging .
The findings European European Committee for Treatment and Multiple Sclerosis Research in Madrid, Spain. Very promising, long-term data via the clinical profile of FTY720, following the publication of one-year Phase II dates in the New England Journal of Medicine on 14 September 2006.
Add MS have, inflammatory lymphocytes , as charge of the destruction of the protective myelin sheath surrounds nerve in key areas the brain and spinal cord of.